Literature DB >> 25971377

Ventilator-associated pneumonia or bacterial colonization of the airway, what do probiotics decrease?

L G Saptharishi1, M Baalaaji, Sunit C Singhi.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25971377     DOI： 10.1007/s00134-015-3767-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Risk factors of ventilator-associated pneumonia in pediatric intensive care unit: a systematic review and meta-analysis.

Authors:  Bo Liu; Song-Qin Li; Su-Ming Zhang; Ping Xu; Xiang Zhang; Yan-Hong Zhang; Wen-Sen Chen; Wei-Hong Zhang
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial.

Authors:  Balasubramaniam Banupriya; Niranjan Biswal; Rangan Srinivasaraghavan; Parameswaran Narayanan; Jharna Mandal
Journal:  Intensive Care Med       Date:  2015-02-24       Impact factor: 17.440

3.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

4.  Diagnosis of ventilator-associated pneumonia in children in resource-limited setting: a comparative study of bronchoscopic and nonbronchoscopic methods.

Authors:  Anil Sachdev; Krishan Chugh; Manpreet Sethi; Dhiren Gupta; Chand Wattal; Geetha Menon
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 5.  Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis.

Authors:  Brennan C Kahan; Tim P Morris
Journal:  BMJ       Date:  2012-09-14
  5 in total
  2 in total

1.  Probiotic prophylaxis to prevent ventilator-associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial--response to comments by Saptharishi et al.

Authors:  Niranjan Biswal; Parameswaran Narayanan; Rangan Srinivasaraghavan; Balasubramaniam Banupriya
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440

2.  Should pediatric infectious diseases physicians be proponents of probiotics?

Authors:  Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jul-Aug       Impact factor: 2.471
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.